"Biosintez" is one of the eldest enterprises of pharmaceutical industry in Russia. The Penza plant of medical preparations was established in 1959. Production of antibiotic substances by fermentation was chosen as a main direction of its activity, and antibiotic biomycin (chlortetracycline) and vitamin B12 were the first products. Later other antibiotic substances were included into product list: oleandomycin, tetracycline, nystatin, heliomycin (Gold medal of Exhibition of Achievements of National Economy in 1970), fusidic acid and sodium fusidate, levorin (candicidin), benzylpenicillin potassium, mycoheptin, as well as cardiovascular riboxin (inosin). Besides the substances, as early as in 1961 the Plant began to produce the formulated preparations, tablets, in 1971 manufactures of infusions and filling of powders for injection were put into operation. Also production of endocrine preparations was organized, in 1986 - insulin, in 1989 - heparin.
Headquarters
Ulitsa Druzhby, Dom 4
Penza; Penza Oblast;
Postal Code: 440013
Contact Details: Purchase the Biosintez PAO report to view the information.
Website: http://biosintez.com/
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service